Loading…
Suboptimal medical therapy in patients with systolic heart failure is associated with less improvement by cardiac resynchronization therapy
Abstract Background Proven medical therapy is under-prescribed in heart failure (HF) for various reasons. Cardiac resynchronization therapy (CRT) is of proven value in selected patients with HF; however, the degree of benefit in those without the optimal therapy is not clear. Methods This is a retro...
Saved in:
Published in: | International journal of cardiology 2007-02, Vol.115 (2), p.214-219 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract Background Proven medical therapy is under-prescribed in heart failure (HF) for various reasons. Cardiac resynchronization therapy (CRT) is of proven value in selected patients with HF; however, the degree of benefit in those without the optimal therapy is not clear. Methods This is a retrospective study comparing the effect of CRT in 30 patients without optimal combination therapy (group 1; 10 (33%) without ACEi or equivalent and 25 (83%) without beta-blockers) to an age, sex, ejection fraction (EF) and New York Heart Association (NYHA) class matched control but with the combination (group 2; n = 30) at baseline. All patients were in NYHA class III or IV with EF ≤ 35% and QRS interval ≥ 120 ms. Echocardiographic examination and N-terminal pro-brain natriuretic peptide (NT pro-BNP) levels before and 3 months after CRT were compared between the two groups. The composite endpoints of HF hospitalization or death during follow-up were compared by Kaplan–Meier analysis. Results There were significantly less improvement in EF (+ 4.0 ± 2.5% vs + 10.1 ± 3.2%; p < 0.05) and degree of reverse remodeling in group 1 after 3 months. Patients in group 1 had significantly higher level of NT pro-BNP levels at 3 months (2221 ± 2001 pg/mL vs 1038 ± 905 pg/mL; p < 0.001) and higher rates of HF hospitalization or death (53.3% vs 23.3%; Log rank χ2 5.52; p = 0.019). Conclusion Patients receiving CRT but without optimal medical therapy were associated with less echocardiographic and clinical improvement. Optimal medical therapy, if tolerated, before CRT is necessary. |
---|---|
ISSN: | 0167-5273 1874-1754 |
DOI: | 10.1016/j.ijcard.2006.04.034 |